A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

Clinical trial NCT00701090 · COMPLETED

Trial details

NCT number: NCT00701090
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2008-05-01
Primary completion: 2009-10-01
Enrollment: 1035

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.